FORTE BIOSCIENCES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
FORTE BIOSCIENCES, INC. (FBRX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$3.66 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-11
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$3.66M, a 197.08% decline year-over-year.
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$28.40M, a 515.28% decline year-over-year.
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $7.57M, a 17.72% increase year-over-year.
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$10.65M, a 228.65% decline year-over-year.
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$27.71M, a 212.78% decline from fiscal 2016.
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $24.57M.
- FORTE BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$24.93M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$3.66M 10-Q · filed 2018-05-11 | -$32.06M derived: sum of 2 quarters · filed 2018-05-11 | -$24.48M derived: sum of 3 quarters · filed 2018-05-11 | -$35.14M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-12-31 | -$28.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$20.82M derived: sum of 2 quarters · filed 2018-03-09 | -$31.48M derived: sum of 3 quarters · filed 2018-03-09 | -$27.71M 10-K · filed 2018-03-09 |
| 2017-09-30 | $7.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$3.08M derived: sum of 2 quarters · filed 2017-11-08 | $690.00K 10-Q · filed 2017-11-08 | $7.53M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-06-30 | -$10.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$6.88M 10-Q · filed 2017-08-09 | -$46.00K derived: sum of 3 quarters · filed 2018-05-11 | $6.39M derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-03-31 | $3.77M 10-Q · filed 2018-05-11 | $10.61M derived: sum of 2 quarters · filed 2018-05-11 | $17.04M derived: sum of 3 quarters · filed 2018-05-11 | $25.32M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $13.27M derived: sum of 2 quarters · filed 2018-03-09 | $21.55M derived: sum of 3 quarters · filed 2018-03-09 | $24.57M 10-K · filed 2018-03-09 |
| 2016-09-30 | $6.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $14.72M derived: sum of 2 quarters · filed 2017-11-08 | $17.73M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $8.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $11.29M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $3.01M 10-Q · filed 2017-05-23 | |||
| 2015-12-31 | -$24.93M 10-K · filed 2018-03-09 |